Continuing to Advance the Venous Agenda: Long-Term Insights From the CAVA Trial
- PMID: 34032123
- PMCID: PMC8483534
- DOI: 10.1161/JAHA.121.021659
Continuing to Advance the Venous Agenda: Long-Term Insights From the CAVA Trial
Keywords: Editorials; chronic venous insufficiency; deep vein thrombosis; postthrombotic syndrome; vein thrombosis; venous thromboembolism; venous thrombosis.
Conflict of interest statement
Obi discloses research funding from Medtronic. Barnes discloses consulting from Janssen, Pfizer/Bristol‐Myers Squibb, and Acelis Connected Health.
Comment on
-
CAVA (Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome) Trial: Long-Term Follow-Up Results.J Am Heart Assoc. 2021 Jun;10(11):e018973. doi: 10.1161/JAHA.120.018973. Epub 2021 May 25. J Am Heart Assoc. 2021. PMID: 34032127 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
